Coronavirus

Europe - Coronavirus

Coronavirus in Europe Essentials publishes only the best news and links related to the Covid-19 virus in Europe, carefully hand-picked and curated by top experts.

Top news of the week: 22.11.2022.

#COVID19
#takeaction
#NICENews
#sotrovimab
#influenza
#Georgia
#flu

@CDCgov shared
On Nov 21, 2022
New in @CDCMMWR: Adults perceiving a high level of #COVID19 community transmission are more likely to take preventive actions, but a low percentage perceived local COVID-19 spread accurately. The more people know, the more likely they are to take action: https://t.co/rhcg0swKUV https://t.co/QvkLNXlsgS
Open
@CDCMMWR shared
On Nov 18, 2022
New MMWR: A higher percentage of parents of vaccinated kids reported perceiving the #COVID19 vaccine as safe than unvaccinated children. Health care provider recommendations & assurances could increase vaccination rates among young children. Learn more: https://t.co/Hvh7aI3SzV https://t.co/kwc5LHJh9j
Open
@bmj_latest shared
On Nov 19, 2022
With the NHS braced for a tough winter, @emahase_ looks at what’s happening with covid tracking and testing, and variants https://t.co/KazIjDpZhG
Open
Covid-19: Is the UK still tracking the virus—and other questions answered

Covid-19: Is the UK still tracking the virus—and other questions answered

With the NHS braced for a tough winter, Elisabeth Mahase looks at what’s happening with covid tracking and testing, and variants Although the UK significantly scaled back its covid ...

@NICEComms shared
On Nov 16, 2022
Three treatments for COVID have been recommended in draft NICE guidance released today. The recommendations published today are draft and could change following public consultation. Find out more: https://t.co/iQqbQy5o62 #NICENews https://t.co/u8oWLKEzrm
Open
NICE recommends 3 treatments for COVID-19 in draft guidance

NICE recommends 3 treatments for COVID-19 in draft guidance

However NICE stands ready to work with companies and NHS England to look for solutions during the public consultation. Recommendations and settings in the draft guidance: Setting …

@bmj_latest shared
On Nov 19, 2022
RT @bmj_company: 🔍 New analysis suggests #sotrovimab remains beneficial in fully vaccinated #covid19 patients.💉🗣️📋 @Roxytonin @_ArlenWilcox @GSK @Vir_Biotech @bmj_latest 📖▶️ https://t.co/hcJLt5FM9W https://t.co/9MmUplZWnm
Open
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform

Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody) with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients ...

@WHO_Europe shared
On Nov 21, 2022
In #Georgia, health workers prepare for a busy winter season - concerned about the surge of #COVID19 & #influenza. Health workers vaccinated against the #flu are more likely to get vaccinated against COVID-19, says recent @WHO_Europe-@NCDCGeorgia study 👇 https://t.co/17tAcWHS4J https://t.co/NqDktyY4Ta
Open
In Georgia, health workers prepare for busy winter season amid COVID-19 and influenza surge concerns

In Georgia, health workers prepare for busy winter season amid COVID-19 and influenza surge concerns

“Does it hurt?” asks Lela Beradze kindly as she administers an influenza vaccine to a health worker at the Botchorishvili Clinic, a large hospital in Tbilisi, Georgia. Lela is Chief Nurse ...

@bmj_latest shared
On Nov 16, 2022
NICE has recommended three drugs—nirmatrelvir plus ritonavir (Paxlovid), tocilizumab (RoActemra), and baricitinib (Olumiant)—for the treatment of covid-19 in adults, as part of draft guidance https://t.co/XU1RniSLuQ
Open
Covid-19: NICE rejects five treatments over uncertain evidence and price in draft guidance

Covid-19: NICE rejects five treatments over uncertain evidence and price in draft guidance

NICE has recommended three drugs—nirmatrelvir plus ritonavir (Paxlovid), tocilizumab (RoActemra), and baricitinib (Olumiant)—for the treatment of covid-19 in adults, as part of draft ...

@TheEconomist shared
On Nov 18, 2022
Having failed to block migrant arrivals, Europe will now have to deal with them. That is where it failed in 2015, and it still does not have a plan https://t.co/1ylF4dHxRh
Open
A new migration crisis is brewing in Europe

A new migration crisis is brewing in Europe

Prepare for populists offering bad solutions